Healthtech innovators are invited to apply to attend a peer-led roundtable to enable shared learning, problem solving and networking.
Engine Shed are thrilled to be partnering with SETsquared Bristol to provide an opportunity for healthtech founders and/or their C-suites to facilitate shared learning, problem solving and skill sharing with real tangible outcomes, as well as to build and strengthen connections within the cluster.
This roundtable is organised by Arne Scott, CTO Rosa Biotech, Yolanda Hill, Business Development Manager Neuronostics and Paul Forster, Business Pre-Incubation Manager SETsquared Bristol.
The roundtable follows SETsquared Bristol’s panel discussion: Healthtech products – from innovation to implementation event at Bristol Technology Festival (see blog for more info here), and subsequent cluster socials.
These events brought together disparate parts of the local healthtech cluster and helped to identify key areas for discussion, development and exploration, and now it’s time to take these forward in this session.
We encourage participants to bring ideas, so if there are any topics or questions you want included on the agenda, please email paul.forster@setsquared.co.uk.
Who is the roundtable for?
We’re inviting regional healthtech founders and C-suite at all stages of their journeys to apply to attend the roundtable, who are keen to help co-create this cluster. This will include founders of established and commercially successful enterprises and and those working on long term product R&D cycles, so we’ll have a wealth of knowledge and experience in the room.
How do you define healthtech?
Companies involved or will be involved in one or more of: clinical or user trials, regulatory approvals, personal healthcare data, selling into healthcare systems. Subsectors: Medical Devices, including Software as a Medical Device, evidence-based Digital Health Technologies, Biosensing, Diagnostics and and therapeutics.
Agenda:
12.00 – Brief introductions
12.15 – Discussion point – Regulatory frameworks and clinical trials
12.45 – Discussion point – Commercial partnerships & industry access, e.g. pharma
1.15 – Discussion point – Funding: grants & equity investment
1.45 – Quick fire problem solving – bring your issues for the roundtable to advise on
2:00 – Close